Jane Street
ZVSA

Jane Street’s ZyVersa Therapeutics ZVSA Stock Holding History

Jane Street’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,212
Closed -$9.09K – 10327
2024
Q1 		$9.09K Buy
+1,212
New +$9.13K ﹤0.01% 8973

Other funds holding ZVSA

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jane Street's ZVSA Position: Q2 2024 in Review

Jane Street sold out of ZyVersa Therapeutics (ZVSA) in Q2 2024, closing a stake of 1,212 shares — an estimated $9.09K sold.

Jane Street first reported a position in ZVSA in Q1 2024 and held it in 1 quarter. The position peaked at $9.09K in Q1 2024. 4 funds tracked by Wall St. Rank hold ZVSA as of Q2 2024.

  • Jane Street reported no remaining ZyVersa Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jane Street sold 1,212 ZyVersa Therapeutics shares in Q2 2024, an estimated $9.09K.
  • Jane Street first reported a position in ZyVersa Therapeutics in Q1 2024 and held it in 1 quarter.
  • Jane Street's ZyVersa Therapeutics position peaked at $9.09K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.